BioWorld MedTech

July 15, 2015

View Archived Issues

DragonBio's remaining stake worth $73 million: Mindray finishes what it started with acquisition of remaining stake in Dragonbio

HONG KONG — Chinese medical device maker, Mindray Medical (Shenzhen) will acquire for $72.6 million the remaining 49% stake in Dragonbio Surgical Implant (Wuhan, China) that it did not acquire in an earlier deal. Read More

Inside the Beltway: FDA applies revised USP standards to draft guidance for heparin-bearing products

Read More

European TechTour Summit: Med-tech becoming increasingly 'personal' as technology improves

Read More

Attitude Adjustment needed: Beltway attitude change needed to spur biomedical investment

Read More

New Trade Association: Association forms to help smaller device firms promote value-based solutions

Read More

Financings: Opgen closes $6M funding headed up by Merck GHI

Read More

World in Review: Danish cancer center first in Europe to use Varian's Calypso transponders

Read More

Agreements/contracts: Multiple company collaboration to fight Type 2 diabetes battle

Read More

Briefly Noted

Read More

Products

Read More

People in Places

Read More

MDD's Oncology Extra

Read More